UPDATE : Monday, September 7, 2020
상단여백
Price cut, expanded indication to prop up cholesterol-reducing PCSK9 inhibitors by Kim Yun-mi 2019-02-13 16:11
Mediforum gets ₩19 billion investment by Lee Han-soo 2019-02-13 15:19
Genexine, SCM Life Science acquire Argos Therapeutics by Lee Han-soo 2019-02-13 15:17
CJ Healthcare to export gastroesophageal reflux treatment to Latin America by Lee Han-soo 2019-02-13 10:50
GC posts ₩1.3 trillion in 2018 sales by Lee Han-soo 2019-02-13 10:50
라인
Bridge Biotherapeutics unveils clinical trials results for ulcerative colitis treatment by Lee Han-soo 2019-02-12 17:38
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs by Kim Yun-mi 2019-02-12 15:56
Pfizer Korea voluntarily recalls antibiotic Zyvox by Lee Hye-seon 2019-02-12 15:56
SK Chemical to co-promote Janssen’s dementia treatment by Lee Han-soo 2019-02-12 15:55
Demands for MMR vaccines spike amid resurgence of measles by Park Gi-taek 2019-02-12 11:19
라인
IVI to cooperate with CEPI to develop vaccines by Lee Han-soo 2019-02-11 16:41
Gilead’s hepatitis B drug posts disappointing sales in 2018 by Kim Yun-mi 2019-02-11 15:29
Sales of antidiabetic SGLT-2 inhibitors expand 40% in 2018 by Kim Yun-mi 2019-02-11 14:35
Novo Nordisk has high expectations for GLP-1 receptor agonists by Kim Yun-mi 2019-02-08 17:11
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list by Park Gi-taek 2019-02-08 16:46
라인
Pangen wins Malaysia’s nod for epoetin alfa biosimilar by Lee Han-soo 2019-02-08 16:13
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea by Kim Yun-mi 2019-02-08 16:12
Multinationals prepare next-generation pneumococcal vaccines by Kim Yun-mi 2019-02-08 12:02
Kainos Medicine starts developing treatment for multiple system atrophy by Lee Han-soo 2019-02-08 11:47
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’ by Lee Han-soo 2019-02-07 17:14
여백
여백
여백
Back to Top